DohlmanCHSchneiderHADoaneMG. Prosthokeratoplasty. Am J Ophthalmol. 1974;77(5):694–670.
2.
TodaniACiolinoJBAmentJD. Titanium back plate for a PMMA keratoprosthesis: clinical outcomes. Graefes Arch Clin Exp Ophthalmol. 2011;249(10):1515–1518.
3.
PaschalisEIChodoshJSpurr-MichaudS. In vitro and in vivo assessment of titanium surface modification for coloring the backplate of the Boston keratoprosthesis. Invest Ophthalmol Vis Sci. 2013;54(6):3863–3873.
4.
ColbyKAKooEB. Expanding indications for the Boston keratoprosthesis. Curr Opin Ophthalmol. 2011;22(4):267–273.
5.
ZerbeBLBelinMWCiolinoJB; Boston Type 1 Keratoprosthesis Study Group. Results from the multicenter Boston type 1 keratoprosthesis study. Ophthalmology. 2006;113(10):1779–1784.
6.
AhmadSMathewsPMLindsleyK. Boston type 1 keratoprosthesis versus repeat donor keratoplasty for corneal graft failure. Ophthalmology. 2016;123(1):165–177.
7.
RudniskyCJBelinMWTodaniA. Risk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: multicenter study results. Ophthalmology. 2012;119(5):951–955.
8.
GoinsKMKitzmannASGreinerMA. Boston type 1 keratoprosthesis: visual outcomes, device retention, and complications. Cornea. 2016;35(9):1165–1174.
9.
NoelCWIsenbergJGoldichY. Type 1 Boston keratoprosthesis: outcomes at two Canadian centres. Can J Ophthalmol. 2016;51(2):76–82.
10.
DuignanESDhubhghaillSNMaloneCPowerW. Long-term visual acuity, retention and complications observed with the type-I and type-II Boston keratoprosthesis in an Irish population. Br J Ophthalmol. 2016;100(8):1093–1097.
11.
SrikumaranDMunozBAldaveAJ. Long-term outcomes of Boston type 1 keratoprosthesis implantation; a retrospective multicenter cohort. Ophthalmology. 2014;121(11):2159–2164.
12.
KornbergDLYannuzziNAKlufasMAD’AmicoDJOrlinAKissS. Ultra-widefield imaging of posterior segment in the setting of Boston keratoprosthesis. Retina. 2016;36(6):1101–1110.
13.
KiangLRosenblattMISartajR. Surface epithelialization of the type I Boston keratoprosthesis front plate: immunohistochemical and high-definition optical coherence tomography characterization. Graefes Arch Clin Exp Ophthalmol. 2012;250(8):1195–1199.
14.
FernandezAGRadcliffeNMSippelKC. Boston type I keratoprosthesis-donor cornea interface evaluated by high-definition spectral-domain anterior segment optical coherence tomography. Clin Ophthalmol. 2012;6:1355–1359.
15.
D’AmicoDJ. New methods for retinal examination in eyes with a Boston keratoprosthesis. Retina. 2013;33(6):1097–1098.
16.
KlufasMAYannuzziNAD’AmicoDJKissS. Vitreoretinal aspects of permanent keratoprosthesis. Surv Ophthalmol. 2015;60(3):216–228.
17.
RaySKhanBFDohlmanCHD’AmicoDJ. Management of vitreoretinal complications in eyes with permanent keratoprosthesis. Arch Ophthalmol. 2002;120(5):559–566.
18.
KiangLSippelKCStarrCE. Vitreoretinal surgery in the setting of permanent keratoprosthesis. Arch Ophthalmol. 2012;130(4):487–492.
19.
RishiPRishiEKoundanyaVVMathurGIyerGSrinivasanB. Vitreoretinal complications in eyes with Boston keratoprosthesis type I. Retina. 2016;36(3):603–610.
20.
GoldmanDRHubschmanJPAldaveAJ. Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis. Retina. 2013;33(3):532–541.
21.
BehlauIMartinKVMartinJN. Infectious endophthalmitis in Boston keratoprosthesis: incidence and prevention. Acta Ophthalmol. 2014;92(7): e546–e555.
22.
FernandezAGSippelKCCiralskyJB. Boston keratoprosthesis. In: PriceFWMcKeeY, eds. The Digital Manual of Ophthalmic Surgery and Theory iBooks; 2014.
23.
OdorcicSSabetiSHaasWDurandMLDohlmanCH. Fungal infections in Boston keratoprosthesis patients: lessons learned and novel developments on the horizon. Semin Ophthalmol. 2016;31(1-2):71–84.
24.
SiglerEJRandolphJCCalzadaJICharlesS. Pars plana vitrectomy with medium-term postoperative perfluoro-N-octane for recurrent inferior retinal detachment complicated by advanced proliferative vitreoretinopathy. Retina. 2013;33(4):791–797.
25.
RobertMCPomerleauVHarissi-DagherM. Complications associated with Boston keratoprosthesis type 1 and glaucoma drainage devices. Br J Ophthalmol. 2013;97(5):573–577.
26.
DohlmanCHD’AmicoDJ. Can an eye with phthisis be rehabilitated? A case of improved vision with 1-year follow-up. Arch Ophthalmol. 1999;117(1):123–124.